Gene · 6368
Papers1,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel chemokine biomarker to distinguish active tuberculosis from latent tuberculosis: a cohort study. | QJM | 2023 | 37740371 | PubTator, text mining | PubMed |
| To target or not to target? The role of DNA and histone methylation in bacterial infections. | Epigenetics | 2023 | 37731322 | PubTator, text mining | PubMed |
| Discovery and pharmacophoric characterization of chemokine network inhibitors using phage-display, saturation mutagenesis and computational modelling. | Nat Commun | 2023 | 37717048 | PubTator, text mining | PubMed |
| Racial differences in serum chemokines in prostate cancer patients. | Cancer | 2023 | 37698493 | PubTator, text mining | PubMed |
| Combining pharmacometric models with predictive and prognostic biomarkers for precision therapy in Crohn's disease: A case study of brazikumab. | CPT Pharmacometrics Syst Pharmacol | 2023 | 37691451 | PubTator, text mining | PubMed |
| Exploration of Key Immune-Related Transcriptomes Associated with Doxorubicin-Induced Cardiotoxicity in Patients with Breast Cancer. | Cardiovasc Toxicol | 2023 | 37684436 | PubTator, text mining | PubMed |
| Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer. | Mol Cancer Ther | 2023 | 37676980 | PubTator, text mining | PubMed |
| Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19. | iScience | 2023 | 37664617 | PubTator, text mining | PubMed |
| Deciphering pathogenic cellular module at single-cell resolution in checkpoint inhibitor-related pneumonitis. | Oncogene | 2023 | 37653115 | PubTator, text mining | PubMed |
| MUC16 stimulates neutrophils to an inflammatory and immunosuppressive phenotype in ovarian cancer. | J Ovarian Res | 2023 | 37644468 | PubTator, text mining | PubMed |
| Coordinated single-cell tumor microenvironment dynamics reinforce pancreatic cancer subtype. | Nat Commun | 2023 | 37633924 | PubTator, text mining | PubMed |
| Molecularly Imprinted Polymers for Pharmaceutical Impurities: Design and Synthesis Methods. | Polymers (Basel) | 2023 | 37631457 | PubTator, text mining | PubMed |
| Genetics of Plasma Bilirubin and Associations between Bilirubin and Cardiometabolic Risk Profiles in Danish Children and Adolescents. | Antioxidants (Basel) | 2023 | 37627608 | PubTator, text mining | PubMed |
| Bile acid-dependent transcription factors and chromatin accessibility determine regional heterogeneity of intestinal antimicrobial peptides. | Nat Commun | 2023 | 37607912 | PubTator, text mining | PubMed |
| Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer. | J Immunother Cancer | 2023 | 37607770 | PubTator, text mining | PubMed |
| Omentum provides a special cell microenvironment for ovarian cancer. | Cancer Rep (Hoboken) | 2023 | 37605299 | PubTator, text mining | PubMed |
| Binding of respiratory syncytial virus particles to platelets does not result in their degranulation in vitro. | Access Microbiol | 2023 | 37601435 | PubTator, text mining | PubMed |
| Molecular disparities in colorectal cancers of White Americans, Alabama African Americans, and Oklahoma American Indians. | NPJ Precis Oncol | 2023 | 37598287 | PubTator, text mining | PubMed |
| The role of the CD8+ T cell compartment in ageing and neurodegenerative disorders. | Front Immunol | 2023 | 37575227 | PubTator, text mining | PubMed |
| The Bladder Tumor Microenvironment Components That Modulate the Tumor and Impact Therapy. | Int J Mol Sci | 2023 | 37569686 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6368/papers?page=10